LC-AMP-F1 Derived from the Venom of the Wolf Spider Lycosa coelestis , Exhibits Antimicrobial and Antibiofilm Activities

• Published in: Pharmaceutics Vol. 16; no. 1; p. 129
• Main Authors: Song, Yuxin, Wang, Junyao, Liu, Xi, Yu, Shengwei, Tang, Xing, Tan, Huaxin
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 19.01.2024; MDPI
• Subjects: antibacterial; antibiofilm; Antibiotics; Antimicrobial agents; antimicrobial peptide; Bacteria; Bacterial infections; Biofilms; E coli; Experiments; LC-AMP-F1; Lycosa coelestis; Peptides; Staphylococcus infections; China; antibacterial; antimicrobial peptide; antibiofilm; Lycosa coelestis; LC-AMP-F1
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics16010129

In recent years, there has been a growing interest in antimicrobial peptides as innovative antimicrobial agents for combating drug-resistant bacterial infections, particularly in the fields of biofilm control and eradication. In the present study, a novel cationic antimicrobial peptide, named LC-AMP-F1, was derived from the cDNA library of the venom gland. The sequence, physicochemical properties and secondary structure of LC-AMP-F1 were predicted and studied. LC-AMP-F1 was tested for stability, cytotoxicity, drug resistance, antibacterial activity, and antibiofilm activity in vitro compared with melittin, a well-studied antimicrobial peptide. The findings indicated that LC-AMP-F1 exhibited inhibitory effects on the growth of various bacteria, including five strains of multidrug-resistant bacteria commonly found in clinical settings. Additionally, LC-AMP-F1 demonstrated effective inhibition of biofilm formation and disruption of mature biofilms. Furthermore, LC-AMP-F1 exhibited favorable stability, minimal hemolytic activity, and low toxicity towards different types of eukaryotic cells. Also, it was found that the combination of LC-AMP-F1 with conventional antibiotics exhibited either synergistic or additive therapeutic benefits. Concerning the antibacterial mechanism, scanning electron microscopy and SYTOX Green staining results showed that LC-AMP-F1 increased cell membrane permeability and swiftly disrupted bacterial cell membranes to exert its antibacterial effects. In summary, the findings and studies facilitated the development and clinical application of novel antimicrobial agents.